CONTRIBUTING SINCE MAY 2013

Kolcuoglu Demirkan Kocakli Attorneys at Law

Kolcuoglu Demirkan Koçakli is a full-service Turkish independent law Firm based in Istanbul, advising international clients on complex Turkish law matters and delivering practical and commercial solutions in M&A, Energy & Infrastructure, Litigation, Arbitration, Corporate & Commercial, Banking & Finance, Compliance, PPP and Employment.
POPULAR TOPICS
Antitrust/Competition Law Corporate/Commercial Law Finance and Banking Real Estate and Construction Privacy

DETAILS

location icon
Turkey
Kolcuoglu Demirkan Kocakli Attorneys at Law weblink
location icon
+90 212 3559900
Photo of Umut Kolcuoglu
Photo of Neyzar Ünübol
Photo of Ali Tunçsav
+106 Authors

COMPANIES CONTENT

Articles
343

AUTHORS

AWARDS
Spring 2024 Award for Data Protection in Turkey
Turkey
Data Protection
Award For:
Article
The New Adequacy Decision For EU-US Data Transfers
Spring 2024 Award for Energy and Natural Resources in Turkey
Turkey
Energy and Natural Resources
Award For:
Article
Turkish Regulation On Electric Vehicle Charging Station Services
Autumn 2023 Award for Compliance in Turkey
Turkey
Compliance
Award For:
Article
The Transition Period To Comply With The New Payment Services Legislation Extended Until 30 April 2023
Autumn 2023 Award for Finance and Banking in Turkey
Turkey
Finance and Banking
Award For:
Article
Collection Of Consumer Finance Loans In Mobile Phone Sales By Mobile Payment Method
Autumn 2023 Award for Media, Telecoms, IT, Entertainment in Turkey
Turkey
Media, Telecoms, IT, Entertainment
Award For:
Article
Collection Of Consumer Finance Loans In Mobile Phone Sales By Mobile Payment Method
Spring 2023 Award for Government, Public Sector in Turkey
Turkey
Government, Public Sector
Award For:
Article
Uyap'tan Karari Görüntüleme Tarihinin Anayasa Mahkemesi'ne Bireysel Başvuru Süresine Etkisi
Autumn 2022 Award for Food, Drugs, Healthcare, Life Sciences in Turkey
Turkey
Food, Drugs, Healthcare, Life Sciences
Award For:
Article
Turkish Competition Authority's Johnson And Johnson Decision Is Annulled: Green Light To Selective Distribution In Pharmaceuticals